Optimization of immunomagnetic selection of myeloma cells from bone marrow using magnetic activated cell sorting

International Journal of Hematology

Volumn 92, Issue 2, 2010, Pages 314-319

  Cumova, Jana ^a   Kovarova, L ^a,b   Potacova, A ^a   Buresova, I ^a,b   Kryukov, F ^a   Penka, M ^b   Michalek, J ^a   Hajek, R ^a,b  

^a MASARYK UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL BRNO   (Czech Republic)

Author keywords

CD138; Immunomagnetic positive selection; Multiple myeloma; Separation strategies

Indexed keywords

ADULT; AGED; ARTICLE; BONE MARROW; CELL SELECTION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOMAGNETIC SEPARATION; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; MYELOMA CELL; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION;

ALGORITHMS; BONE MARROW; HUMANS; IMMUNOMAGNETIC SEPARATION; METHODS; MULTIPLE MYELOMA; SOFTWARE;

EID: 77956929651     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-010-0651-4     Document Type: Article

References (17)

1. BG Durie RA Kyle A Belch W Bensinger J Blade M Boccadoro, et al. 2003 Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation Hematol J 4 379 398 10.1038/sj.thj. 6200312 14671610 Erratum in: Hematol J. 2004;5:285 (Pubitemid 38088783)
2. R Fonseca PL Bergsagel J Drach J Shaughnessy N Gutierrez AK Stewart, et al. 2009 International Myeloma Working Group molecular classification of mutliple myeloma: spotlight review Leukemia 23 2210 2221 1:STN:280: DC%2BD1MfivVGitg%3D%3D 10.1038/leu.2009.174 19798094
3. H Tsutsui CM Ho 2009 Cell separation by non-inertial force fields in microfluidic systems Mech Res Commun 36 92 103 10.1016/j.mechrescom.2008.08.006 20046897
4. J Drach J Schuster H Nowotny J Angerler F Rosenthal M Fiegl, et al. 1995 Multiple myeloma: high incidence of chromosomal aneuploidy as detected by interphase fluorescence in situ hybridization Cancer Res 55 3854 3859 1:CAS:528:DyaK2MXnvVeltrg%3D 7641204
5. A Draube R Pfister M Vockerodt S Schuster D Kube V Diehl, et al. 2001 Immunomagnetic enrichment of CD138 positive cells from weakly infiltrated myeloma patients samples enables the determination of the tumor clone specific IgH rearrangement Ann Hematol 80 83 89 1:STN:280:DC%2BD3M7mtVagtA%3D%3D 10.1007/s002770000245 11261330 (Pubitemid 32177953)
6. J Wijdenes WC Vooijs C Clément J Post F Morard N Vita, et al. 1996 A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1 Br J Haematol 94 318 323 1:CAS:528:DyaK28Xltlahtr4%3D 10.1046/j.1365-2141.1996.d01- 1811.x 8759892
7. W Matsui CA Huff Q Wang MT Malehorn J Barber Y Tanhehco, et al. 2004 Characterization of clonogenic multiple myeloma cells Blood 103 2332 2336 1:CAS:528:DC%2BD2cXitlCjs74%3D 10.1182/blood-2003-09-3064 14630803 (Pubitemid 38326254)
8. TE Witzig T Kimlinger M Stenson T Therneau 1998 Syndecan-1 expression on malignant cells from the blood and marrow of patients with plasma cell proliferative disorders and B-cell chronic lymphocytic leukemia Leuk Lymphoma 31 167 175 1:CAS:528:DC%2BD3cXlsV2rs7w%3D 9720726
9. M Bernfield R Kokenyesi M Kato MT Hinkes J Spring RL Gallo, et al. 1992 Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans Ann Rev Cell Biol 8 365 393 1:CAS:528:DyaK3sXls1OntA%3D%3D 1335744
10. A Fišerová R Hájek V Holubová T Büchler J Sobotka L Kovářová, et al. 2002 Detection of 13q abnormalities in multiple myeloma using immunomagnetically selected plasma cells Neoplasma 49 300 306 12458327
11. L Kovarova I Buresova T Buchler R Suska L Pour L Zahradova, et al. 2009 Phenotype of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significance Neoplasma 56 526 532 1:CAS:528:DC%2BD1MXht12hu7zP 10.4149/neo-2009-06-526 19728762
12. M Jourdan M Ferlin E Legouffe M Horvathova J Liautard JF Rossi, et al. 1998 The myeloma cell antigen syndecan-1 is lost by apoptotic myeloma cells Br J Haematol 100 637 646 1:STN:280:DyaK1c7ovFyitw%3D%3D 10.1046/j.1365-2141.1998. 00623.x 9531328 (Pubitemid 28126093)
13. R Fonseca B Barlogie R Bataille C Bastard PL Bergsagel M Chesi, et al. 2004 Genetics and cytogenetics of multiple myeloma: a workshop report Cancer Res 64 1546 1558 1:CAS:528:DC%2BD2cXhtleitb4%3D 10.1158/0008-5472.CAN-03-2876 14989251 (Pubitemid 38235629)
14. M Borset E Helseth B Naume A Waage 1993 Lack of IL-1 secretion from human myeloma cells highly purified by immunomagnetic separation Br J Haematol 85 446 451 1:STN:280:DyaK2c7otlOitA%3D%3D 10.1111/j.1365-2141.1993.tb03331.x 8136264
15. GJ Ahmann WJ Chng KJ Henderson TL Price-Troska RW DeGoey MM Timm, et al. 2008 Effect of tissue shipping on plasma cell isolation, viability, and RNA integrity in the kontext a centralized good laboratory practice-certified tissue banking facility Cancer Epidemiol Biomarkers Prev 17 666 673 1:CAS:528:DC%2BD1cXjtlKhsbo%3D 10.1158/1055-9965.EPI-07-2649 18349285 (Pubitemid 351469218)
16. S Miltenyi W Müller W Weichel A Radbruch 1990 High gradient magnetic cell separation with MACS Cytometry 11 231 238 1:STN:280:DyaK3c3gtVKmug%3D%3D 10.1002/cyto.990110203 1690625
17. HA Minges Wols PL Witte 2008 Plasma cell purification from murine bone marrow using a two-step isolation approach J Immunol Methods 329 219 224 1:CAS:528:DC%2BD2sXhsVeqtbzP 10.1016/j.jim.2007.09.012 18021796 (Pubitemid 350245502)